News Focus
News Focus
icon url

DewDiligence

06/25/19 11:23 AM

#225389 RE: Bickema #225387

ABBV—Seems like an overreaction, but: i) Nobody saw this deal coming, so there’s more of a kneejerk sell-off impulse than in a typical large merger; and ii) Few investors truly understand how great a global franchise Botox is (#msg-147281766).